Maxcyte, Inc.
MXCT
Revenue
4.97M
▼-619.00k▼-11.09%
3 Months ChangeAssets
251.50M
▼-6.43M▼-2.49%
3 Months ChangeLiabilities
30.24M
▼-1.34M▼-4.23%
3 Months ChangeFree Cash Flow
-11.37M
▼-5.49M▼-93.27%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-15
Form 8-K
ID: 0001558370-24-013318
2024-08-06
Form 10-Q
ID: 0001558370-24-011120
2024-08-06
Form 8-K
ID: 0001558370-24-011088
2024-06-12
Form 8-K
ID: 0001558370-24-009097
2024-05-07
Form 10-Q
ID: 0001558370-24-007085
2024-05-07
Form 8-K
ID: 0001558370-24-007051
2024-03-12
Form 8-K
ID: 0001558370-24-002986
2024-03-05
Form 8-K
ID: 0001558370-24-002480
2024-01-26
Form 8-K
ID: 0001558370-24-000593
2024-01-08
Form 8-K
ID: 0001558370-24-000136